Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
2.704
+0.004 (0.13%)
Aug 14, 2025, 11:44 AM - Market open
Annovis Bio Employees
As of December 31, 2024, Annovis Bio had 15 total employees, including 8 full-time and 7 part-time employees. The number of employees decreased by 1 or -6.25% compared to the previous year.
Employees
15
Change (1Y)
-1
Growth (1Y)
-6.25%
Revenue / Employee
n/a
Profits / Employee
-$2,017,343
Market Cap
52.68M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 15 | -1 | -6.25% |
| Dec 31, 2023 | 16 | 11 | 220.00% |
| Dec 31, 2022 | 5 | 2 | 66.67% |
| Dec 31, 2021 | 3 | 1 | 50.00% |
| Dec 31, 2020 | 2 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ANVS News
- 1 day ago - Annovis Provides Corporate Updates and Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 7 days ago - Annovis Completes Full Patent Transfer to Crystal Buntanetap - GlobeNewsWire
- 7 weeks ago - Annovis to Attend the AAIC 2025 with Four Poster Presentations - GlobeNewsWire
- 2 months ago - Annovis Announces NYSE Acceptance of Plan to Regain Listing Compliance - GlobeNewsWire
- 2 months ago - Annovis to Host Webinar and Live Q&A on June 24, 2025 - GlobeNewsWire
- 3 months ago - Annovis Provides Corporate Updates and Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - Annovis Bio Appoints Hui Liu as Director of Biostatistics - GlobeNewsWire
- 4 months ago - Annovis Bio, Inc. Receives Continued Listing Standard Notice From the NYSE - GlobeNewsWire